Robert D Bennett

Dr. Robert D Bennett

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2024 in Gut
Verified
Journal Article
Open access
PDF file
RSRamani Soundararajan
Ramani Soundararajan
MMMichelle M Maurin
Michelle M Maurin
JRJetsen Rodriguez-Silva
Jetsen Rodriguez-Silva
GUGunjan Upadhyay
Gunjan Upadhyay
AAAshley J. Alden
Ashley J. Alden
TYTimothy Yeatman
Timothy Yeatman
Background Over a century ago, Virchow proposed that cancer represents a chronically inflamed, poorly healing wound. Normal wound healing is represented by a transitory phase of inflammation, followed by a pro-resolution phase, with prostaglandin (PGE2/PGD2)-induced ‘lipid class switching’ producing inflammation-quenching lipoxins (LXA4, LXB4). Objective We explored if lipid dysregulation in colorectal cancers (CRCs) is driven by a failure to resolve inflammation. Design We performed liquid chromatography and tandem mass spectrometry (LC–MS/MS) untargeted analysis of 40 human CRC and normal paired samples and targeted, quantitative analysis of 81 human CRC and normal paired samples. We integrated analysis of lipidomics, quantitative reverse transcription-PCR, large scale gene expression, and spatial transcriptomics with public scRNASEQ data to characterize pattern, expression and cellular localisation of genes that produce and modify lipid mediators. Results Targeted, quantitative LC–MS/MS demonstrated a marked imbalance of pro-inflammatory mediators, with a dearth of resolving lipid mediators. In tumours, we observed prominent over-expression of arachidonic acid derivatives, the genes encoding their synthetic enzymes and receptors, but poor expression of genes producing pro-resolving synthetic enzymes and resultant lipoxins (LXA4, LXB4) and associated receptors. These results indicate that CRC is the product of defective lipid class switching likely related to inadequate or ineffective levels of PGE2/PGD2. Conclusion We show that the lipidomic profile of CRC tumours exhibits a distinct pro-inflammatory bias with a deficiency of endogenous resolving mediators secondary to defective lipid class switching. These observations pave the way for ‘resolution medicine’, a novel therapeutic approach for inducing or providing resolvins to mitigate the chronic inflammation driving cancer growth and progression.

24 September 2023 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
JRJetsen A. Rodriguez-Silva
Jetsen A. Rodriguez-Silva
WDWilliam Doyle
William Doyle
AAAshley J. Alden
Ashley J. Alden
SPSharan Poonja
Sharan Poonja
CMCarolina Martinez
Carolina Martinez
RBRobert D Bennett
Robert D Bennett


15 March 2026 in Journal of Minimally Invasive Surgery
Verified
Journal Article
Open access
PDF file
WDWilliam N. Doyle
William N. Doyle
AAAshley J. Alden
Ashley J. Alden
JRJetsen A. Rodriguez-Silva
Jetsen A. Rodriguez-Silva
JKJin Kim
Jin Kim
SPSharan Poonja
Sharan Poonja
RBRobert D Bennett
Robert D Bennett
William N. Doyle Jr, Ashley J. Alden, Jetsen A. Rodriguez-Silva, Jin Kim, Sharan Poonja, Melissa A. Kendall, Kaylee Smith, Carolina Martinez, Allen Chudzinski, Lisa Moudgill, Paul Cavallaro, Jorge E. Marcet, Robert D. Bennett. Journal of Minimally Invasive Surgery 2026;29:22-30. https://doi.org/10.7602/jmis.2026.29.1.22

20 November 2025 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
AAAshley J. Alden
Ashley J. Alden
JKJin K. Kim
Jin K. Kim
KSKaiser O'Sahil Sadiq
Kaiser O'Sahil Sadiq
KSKaylee Smith
Kaylee Smith
PCPaul Cavallaro
Paul Cavallaro
RBRobert D Bennett
Robert D Bennett

30 October 2025 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
AAAshley J. Alden
Ashley J. Alden
JKJin K. Kim
Jin K. Kim
KSKaiser Sadiq
Kaiser Sadiq
KSKaylee Smith
Kaylee Smith
PCPaul Cavallaro
Paul Cavallaro
RBRobert D Bennett
Robert D Bennett